Streetbeat News

DOC

Healthpeak Properties, Inc.

https://www.healthpeak.com

Industry

REIT - Healthcare Facilities

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Citigroup analyst Michael Bilerman maintains a Neutral rating on Healthpeak Properties and raises the price target from $20 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 3:26 pm

Analysts have provided mixed evaluations for Healthpeak Properties (NYSE:DOC) over the past three months, with a majority leaning towards a somewhat bullish outlook. The average 12-month price target has increased to $23.5, reflecting a 10.59% rise from the previous target. Key analysts from RBC Capital, Wedbush, Scotiabank, and JP Morgan have raised their price targets, indicating positive sentiment towards the company's future performance.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 1:01 pm

RBC Capital analyst Michael Carroll maintains an Outperform rating on Healthpeak Properties (NYSE:PEAK) and raises the price target from $22 to $25.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:41 pm

Wedbush analyst Richard Anderson maintains an Outperform rating on Healthpeak Properties (NYSE:DOC) and raises the price target from $22 to $25.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:14 pm

Healthpeak Properties shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 earnings guidance.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 3:47 pm

Healthpeak Properties has increased its FY24 diluted earnings guidance from $0.16-$0.20 to $0.27-$0.31 per share. The company also raised the midpoint of its 2024 FFO as adjusted and AFFO guidance by $0.01 per share.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 8:54 pm

Healthpeak Properties (NYSE:DOC) reported Q2 earnings of $0.45 per share, beating the $0.44 estimate and showing an 80% increase from last year. Sales were $695.50M, surpassing the $660.55M estimate and marking a 27.51% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 8:52 pm

Analysts' ratings for Healthpeak Properties (NYSE:PEAK) vary from bullish to bearish, with recent evaluations showing a positive shift in price targets. The average 12-month price target has risen by 9.3% to $21.86. Key analysts from firms like Scotiabank, JP Morgan, and B of A Securities have raised their price targets, reflecting improved market sentiment. Despite positive revenue growth, Healthpeak faces challenges in profitability and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

May 16, 2024 | 2:00 pm

Scotiabank analyst Nicholas Yulico maintains a Sector Outperform rating on Healthpeak Properties (NYSE:DOC) and raises the price target from $22 to $23.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 1:26 pm

JP Morgan analyst Michael Mueller maintains a Neutral rating on Healthpeak Properties (NYSE:DOC) and raises the price target from $19 to $21.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:29 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.